Background Gallium 68–labeled fibroblast-activation protein inhibitor (68Ga-FAPI), an
imaging agent for detecting tumors, represents a promising alternative to fluorine 18 …

The purpose of this study was to determine the glucose metabolism at delay phase
measured by pretreatment dual-time-point 18 F-fluorodeoxyglucose (18 F-FDG) positron …

Dear Sir, We read with great interest the recent article by Dr. Chen et al. titled “Comparison
of [68Ga] Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and …

Background The diagnosis and staging of hilar cholangiocarcinoma (HCCA) remain
challenging despite recent advances in imaging. Little is known about the use of positron …

Objective The limited studies with 18 F-fluorodeoxyglucose (18 F-FDG)-PET reported results
and interpretations that differed between hepatocellular carcinoma (HCC) and intrahepatic …

The combination of positron emission tomography (PET) with computed tomography (PET‐
CT) provides simultaneous metabolic and anatomic information on tumors in the same …

Purpose The diagnostic accuracy of [18 F] fluorodeoxyglucose (FDG) PET is insufficient to
characterise hepatocellular carcinoma (HCC) in liver masses and to diagnose all cases of …

Rationale and Objectives To evaluate the results of 18F-FDG PET/MRI in relation to the
histopathologic subtypes and histologic grades of mass-forming primary intrahepatic …

Objectives Although diffuse splenic 18 F-fluorodeoxyglucose (F-18 FDG) uptake exceeding
hepatic activity, is considered abnormal, its clinical significance is rarely discussed in the …

Aim: We investigated the prognostic value of clinicopathological factors in patients with a
distal bile duct adenocarcinoma after curative resection. Patients and Methods: This …